Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
MY TRIALS
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Register a trial
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT03611478
Registration number
NCT03611478
Ethics application status
Date submitted
26/07/2018
Date registered
2/08/2018
Titles & IDs
Public title
Examining the Effects of One-Month Probiotic Treatment on Mental Fatigue
Query!
Scientific title
Examining the Effects of One-Month Probiotic Treatment on Mental Fatigue
Query!
Secondary ID [1]
0
0
NH-03884
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Mental Fatigue
0
0
Query!
Cognitive Function
0
0
Query!
Mood
0
0
Query!
Condition category
Condition code
Mental Health
0
0
0
0
Query!
Other mental health disorders
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Other - Probiotic formulation
Treatment: Other - Placebo
Experimental: Probiotic formulation - Contains a probiotic formulation. One capsule to be taken by mouth once daily for 28 days.
Placebo comparator: Placebo - Matching placebo to be taken once daily by mouth for 28 days.
Treatment: Other: Probiotic formulation
Probiotic capsule
Treatment: Other: Placebo
Placebo capsule identical in taste and appearance to probiotic capsule
Query!
Intervention code [1]
0
0
Treatment: Other
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Mental fatigue score (VAS-mental fatigue)
Query!
Assessment method [1]
0
0
Difference in mental fatigue score as the participant moves through six cycles of a cognitive demand battery (CDB). The cognitive demand battery consists of three tasks (RVIP, serial threes and serial sevens, described below), and is designed to increase cognitive load. Six cycles of the battery are completed in succession at each testing visit. The mental fatigue scale (VAS-mental fatigue) is completed after each cycle of the CDB (6 times over the course of one hour, per visit). Participants rate their level of mental fatigue on a 100-mm scale from "not at all" to "extremely". The primary outcome is difference in mental fatigue score (VAS-mental fatigue) as the participant moves through the six cycles of the CDB, (after cognitive load) absolute change from baseline (Visit 2) to 28 days (Visit 3) between the active vs placebo group.
Query!
Timepoint [1]
0
0
28 days
Query!
Secondary outcome [1]
0
0
RVIP number correct
Query!
Assessment method [1]
0
0
Percentage of target strings correctly detected on the rapid visual information processing (RVIP) task throughout each of the six cycles of the CDB. In this task, which lasts for 5 minutes, a series of numbers rapidly appear on the screen one at a time. Participants are instructed to press the space bar whenever they detect a sequence of either 3 consecutive odd or 3 consecutive even numbers.
Query!
Timepoint [1]
0
0
28 days
Query!
Secondary outcome [2]
0
0
RVIP reaction time
Query!
Assessment method [2]
0
0
Average reaction time for correct detections (RVIP) throughout each of the six cycles of the CDB.
Query!
Timepoint [2]
0
0
28 days
Query!
Secondary outcome [3]
0
0
RVIP false alarms
Query!
Assessment method [3]
0
0
The number of false alarms (RVIP) throughout each of the six cycles of the CDB
Query!
Timepoint [3]
0
0
28 days
Query!
Secondary outcome [4]
0
0
Serial threes subtraction total
Query!
Assessment method [4]
0
0
Total number of subtractions on the serial threes subtraction task, regardless of whether correct or incorrect, throughout each of the six cycles of the CDB. In this two minute task, participants are given a starting number and instructed to subtract three from this number. They must then type in the number they are left with and press enter. After this no numbers are visible but the participant must continue to subtract three and enter their responses.
Query!
Timepoint [4]
0
0
28 days
Query!
Secondary outcome [5]
0
0
Serial threes errors
Query!
Assessment method [5]
0
0
Total number of incorrect subtractions (serial threes subtraction task) throughout each of the six cycles of the CDB
Query!
Timepoint [5]
0
0
28 days
Query!
Secondary outcome [6]
0
0
Serial sevens total
Query!
Assessment method [6]
0
0
Total number of subtractions (serial sevens subtraction task) throughout each of the six cycles of the CDB. This task is the same as the serial threes task, except that participants must subtract seven instead of three.
Query!
Timepoint [6]
0
0
28 days
Query!
Secondary outcome [7]
0
0
Serial sevens errors
Query!
Assessment method [7]
0
0
Total number of errors (serial sevens subtraction task) throughout each of the six cycles of the CDB
Query!
Timepoint [7]
0
0
28 days
Query!
Secondary outcome [8]
0
0
Immediate word recall - correct
Query!
Assessment method [8]
0
0
The number of correctly identified words in the immediate word recall task. Participants see a list of 15 words that they are instructed to remember. After seeing the last word, the participant has 60 seconds to write down as many of the words as they can remember.
Query!
Timepoint [8]
0
0
28 days
Query!
Secondary outcome [9]
0
0
Immediate word recall - errors
Query!
Assessment method [9]
0
0
The number of errors in the immediate word recall task (words not included in the original list)
Query!
Timepoint [9]
0
0
28 days
Query!
Secondary outcome [10]
0
0
Immediate word recall - intrusions
Query!
Assessment method [10]
0
0
The number of intrusions in the immediate word recall task (words similar to those included in the original list but not identical).
Query!
Timepoint [10]
0
0
28 days
Query!
Secondary outcome [11]
0
0
Delayed word recall - Correct
Query!
Assessment method [11]
0
0
The number of correctly identified words in the delayed word recall task. After completing the CDB (approximately one hour after presentation of the 15 words), the participant has 60 seconds to write down as many of the words as they can remember from the original list.
Query!
Timepoint [11]
0
0
28 days
Query!
Secondary outcome [12]
0
0
Delayed word recall - errors
Query!
Assessment method [12]
0
0
The number of errors in the delayed word recall task (words not included in the original list)
Query!
Timepoint [12]
0
0
28 days
Query!
Secondary outcome [13]
0
0
Delayed word recall - intrusions
Query!
Assessment method [13]
0
0
The number of intrusions in the delayed word recall task (words similar to those included in the original list but not identical).
Query!
Timepoint [13]
0
0
28 days
Query!
Secondary outcome [14]
0
0
Delayed word recognition - reaction time
Query!
Assessment method [14]
0
0
Mean reaction time to word recognition in delayed word recognition task following cognitive load. After participants have viewed the word list and completed the immediate word recall task, they complete the CDB which lasts for one hour. On completion of the CDB, participants complete a word recognition task. In this task, the original 15 target words plus an additional 15 distractor words are presented one at a time, in a randomized order. Participants are instructed to indicate whether or not they recognize the word from the original list by pressing the 'Yes' or 'No' button as appropriate as quickly as possible, mean reaction times are measured in msec.
Query!
Timepoint [14]
0
0
28 days
Query!
Secondary outcome [15]
0
0
Word recognition - original words accuracy
Query!
Assessment method [15]
0
0
Accuracy of responses (%) to original target words in delayed word recognition task following cognitive load (CDB).
Query!
Timepoint [15]
0
0
28 days
Query!
Secondary outcome [16]
0
0
Word recognition - distractor words accuracy
Query!
Assessment method [16]
0
0
Accuracy of responses (%) to novel distractor words in delayed word recognition following cognitive load (CDB).
Query!
Timepoint [16]
0
0
28 days
Query!
Secondary outcome [17]
0
0
Self-reported alertness score
Query!
Assessment method [17]
0
0
Participants are presented with a number of 100-mm visual analogue scales (Bond-Lader mood scales) where they indicate their current feelings. The alertness score is calculated by averaging scores on lines anchored by alert-drowsy, attentive-dreamy, lethargic-energetic, muzzy-clearheaded, well-coordinated-clumsy, mentally slow-quick witted, strong-feeble, interested-bored, incompetent-proficient. This is completed before and after the CDB.
Query!
Timepoint [17]
0
0
28 days
Query!
Secondary outcome [18]
0
0
Self-reported contentment score
Query!
Assessment method [18]
0
0
Participants are presented with a number of 100-mm visual analogue scales (Bond-Lader mood scales) where they indicate their current feelings. The contentment score is calculated by averaging scores on lines anchored by contented-discontented, troubled-tranquil, happy-sad, antagonistic-friendly, withdrawn-sociable. This is completed before and after the CDB.
Query!
Timepoint [18]
0
0
28 days
Query!
Secondary outcome [19]
0
0
Self-reported calmness score
Query!
Assessment method [19]
0
0
Participants are presented with a number of 100-mm visual analogue scales (Bond-Lader mood scales) where they indicate their current feelings. The calmness score is calculated by averaging scores on lines anchored by calm-excited, tense-relaxed. This is completed before and after the CDB.
Query!
Timepoint [19]
0
0
28 days
Query!
Secondary outcome [20]
0
0
Difference in self-reported stress score (VAS-stress) before and after a cognitive load
Query!
Assessment method [20]
0
0
The Stress Visual Analogue Scale (VAS-Stress) consists of a single 100 mm line with end-points labelled 'Not at all' and 'Very much so'. Participants are instructed to mark the line, depending on how "stressed" they feel at that point in time. This is completed twice in each session, once prior to the CDB, and once after the battery is complete. The difference between pre- and post-CDB score is calculated, and the difference is compared between baseline and 28 days.
Query!
Timepoint [20]
0
0
28 days
Query!
Secondary outcome [21]
0
0
Self-reported stress score (VAS-stress) - pre-CDB only
Query!
Assessment method [21]
0
0
The Stress Visual Analogue Scale (VAS-Stress) consists of a single 100 mm line with end-points labelled 'Not at all' and 'Very much so'. Participants are instructed to mark the line, depending on how "stressed" they feel at that point in time. The pre-CDB score is compared between baseline and 28 days to provide an assessment of stress without cognitive load.
Query!
Timepoint [21]
0
0
28 days
Query!
Secondary outcome [22]
0
0
Difference in self-reported physical fatigue score (VAS-fatigue) before and after a cognitive load
Query!
Assessment method [22]
0
0
The Physical Fatigue Visual Analogue Scale (VAS-fatigue) consists of a single 100 mm line with end-points labelled 'Not at all' and 'Very much so'. Participants are instructed to mark the line, depending on how "physically fatigued" they feel at that point in time. This is completed twice in each session, once prior to the CDB, and once after the battery is complete. The difference between pre- and post-CDB score is calculated, and the difference is compared between baseline and 28 days.
Query!
Timepoint [22]
0
0
28 days
Query!
Secondary outcome [23]
0
0
Self-reported physical fatigue score (VAS-fatigue) - pre-CDB only
Query!
Assessment method [23]
0
0
The Physical Fatigue Visual Analogue Scale (VAS-Fatigue) consists of a 100 mm line with end-points labelled 'Not at all' and 'Very much so'. Participants are instructed to mark the line, depending on how "physically fatigued" they feel at that point in time. The pre-CDB score is compared between baseline and 28 days to provide an assessment of physical fatigue without cognitive load.
Query!
Timepoint [23]
0
0
28 days
Query!
Secondary outcome [24]
0
0
Self-reported state anxiety (STAI) before and after a cognitive load
Query!
Assessment method [24]
0
0
The 'State' subscale of the STAI contains 20 items, and requires participants to rate how much they feel like each item at the time of response. The scale is scored on a 4-point scale ranging from 'not at all' to 'very much so'. Scores range from 20 to 80, with higher scores indicating higher levels of anxiety. Participants will be required to complete the state version of the STAI twice per session, once before the commencement of the CDB, and once at completion.
Query!
Timepoint [24]
0
0
28 days
Query!
Secondary outcome [25]
0
0
Mental fatigue score on the Chalder Fatigue Scale
Query!
Assessment method [25]
0
0
The 14-item Chalder Fatigue Scale (CFS) measures both physical and mental fatigue, as well as a total fatigue rating, on a 4-point scale ranging from 'better than usual' to 'much worse than usual'.
Query!
Timepoint [25]
0
0
28 days
Query!
Secondary outcome [26]
0
0
Physical fatigue score on the Chalder Fatigue Scale
Query!
Assessment method [26]
0
0
The 14-item CFS measures both physical and mental fatigue, as well as a total fatigue rating, on a 4-point scale ranging from 'better than usual' to 'much worse than usual'.
Query!
Timepoint [26]
0
0
28 days
Query!
Secondary outcome [27]
0
0
Total fatigue score on the Chalder Fatigue Scale
Query!
Assessment method [27]
0
0
The 14-item CFS measures both physical and mental fatigue, as well as a total fatigue rating, on a 4-point scale ranging from 'better than usual' to 'much worse than usual'.
Query!
Timepoint [27]
0
0
28 days
Query!
Secondary outcome [28]
0
0
Self-reported sleep quality - total score
Query!
Assessment method [28]
0
0
The Pittsburgh Sleep Quality Index (PSQI) was originally designed to measure sleep quality and disturbance in clinical populations, and has been subsequently utilized in a number of research settings. The PSQI is a self-rated scale measured over a one-month interval. The scale is comprised of 19 individual items that generate 7 "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleep medications, and daytime dysfunction. The scale also has five items to be answered by a bed partner, if applicable, but these answers are not included in the scoring of the scale. For the current study, these five questions will be removed from the scale.
Query!
Timepoint [28]
0
0
28 days
Query!
Secondary outcome [29]
0
0
Self-reported duration of sleep score
Query!
Assessment method [29]
0
0
The Pittsburgh Sleep Quality Index (PSQI) was originally designed to measure sleep quality and disturbance in clinical populations, and has been subsequently utilized in a number of research settings. The PSQI is a self-rated scale measured over a one-month interval. The scale is comprised of 19 individual items that generate 7 "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleep medications, and daytime dysfunction. The scale also has five items to be answered by a bed partner, if applicable, but these answers are not included in the scoring of the scale. For the current study, these five questions will be removed from the scale.
Query!
Timepoint [29]
0
0
28 days
Query!
Secondary outcome [30]
0
0
Self-reported sleep disturbance score
Query!
Assessment method [30]
0
0
The Pittsburgh Sleep Quality Index (PSQI) was originally designed to measure sleep quality and disturbance in clinical populations, and has been subsequently utilized in a number of research settings. The PSQI is a self-rated scale measured over a one-month interval. The scale is comprised of 19 individual items that generate 7 "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleep medications, and daytime dysfunction. The scale also has five items to be answered by a bed partner, if applicable, but these answers are not included in the scoring of the scale. For the current study, these five questions will be removed from the scale.
Query!
Timepoint [30]
0
0
28 days
Query!
Secondary outcome [31]
0
0
Self-reported sleep latency score
Query!
Assessment method [31]
0
0
The Pittsburgh Sleep Quality Index (PSQI) was originally designed to measure sleep quality and disturbance in clinical populations, and has been subsequently utilized in a number of research settings. The PSQI is a self-rated scale measured over a one-month interval. The scale is comprised of 19 individual items that generate 7 "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleep medications, and daytime dysfunction. The scale also has five items to be answered by a bed partner, if applicable, but these answers are not included in the scoring of the scale. For the current study, these five questions will be removed from the scale.
Query!
Timepoint [31]
0
0
28 days
Query!
Secondary outcome [32]
0
0
Self-reported daytime dysfunction score
Query!
Assessment method [32]
0
0
The Pittsburgh Sleep Quality Index (PSQI) was originally designed to measure sleep quality and disturbance in clinical populations, and has been subsequently utilized in a number of research settings. The PSQI is a self-rated scale measured over a one-month interval. The scale is comprised of 19 individual items that generate 7 "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleep medications, and daytime dysfunction. The scale also has five items to be answered by a bed partner, if applicable, but these answers are not included in the scoring of the scale. For the current study, these five questions will be removed from the scale.
Query!
Timepoint [32]
0
0
28 days
Query!
Secondary outcome [33]
0
0
Self-reported habitual sleep efficiency score
Query!
Assessment method [33]
0
0
The Pittsburgh Sleep Quality Index (PSQI) was originally designed to measure sleep quality and disturbance in clinical populations, and has been subsequently utilized in a number of research settings. The PSQI is a self-rated scale measured over a one-month interval. The scale is comprised of 19 individual items that generate 7 "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleep medications, and daytime dysfunction. The scale also has five items to be answered by a bed partner, if applicable, but these answers are not included in the scoring of the scale. For the current study, these five questions will be removed from the scale.
Query!
Timepoint [33]
0
0
28 days
Query!
Secondary outcome [34]
0
0
Subjective sleep quality score
Query!
Assessment method [34]
0
0
The Pittsburgh Sleep Quality Index (PSQI) was originally designed to measure sleep quality and disturbance in clinical populations, and has been subsequently utilized in a number of research settings. The PSQI is a self-rated scale measured over a one-month interval. The scale is comprised of 19 individual items that generate 7 "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleep medications, and daytime dysfunction. The scale also has five items to be answered by a bed partner, if applicable, but these answers are not included in the scoring of the scale. For the current study, these five questions will be removed from the scale.
Query!
Timepoint [34]
0
0
28 days
Query!
Secondary outcome [35]
0
0
Self-reported use of sleep medications score
Query!
Assessment method [35]
0
0
The Pittsburgh Sleep Quality Index (PSQI) was originally designed to measure sleep quality and disturbance in clinical populations, and has been subsequently utilized in a number of research settings. The PSQI is a self-rated scale measured over a one-month interval. The scale is comprised of 19 individual items that generate 7 "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbance, use of sleep medications, and daytime dysfunction. The scale also has five items to be answered by a bed partner, if applicable, but these answers are not included in the scoring of the scale. For the current study, these five questions will be removed from the scale.
Query!
Timepoint [35]
0
0
28 days
Query!
Secondary outcome [36]
0
0
Self-reported vitality score (SF-36)
Query!
Assessment method [36]
0
0
The SF-36 is a 36-item survey of health and well-being. The scale consists of eight domains: vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning and mental health. The SF-36 will be completed once per session.
Query!
Timepoint [36]
0
0
28 days
Query!
Secondary outcome [37]
0
0
Self-reported physical functioning score (SF-36)
Query!
Assessment method [37]
0
0
The SF-36 is a 36-item survey of health and well-being. The scale consists of eight domains: vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning and mental health. The SF-36 will be completed once per session.
Query!
Timepoint [37]
0
0
28 days
Query!
Secondary outcome [38]
0
0
Self-reported bodily pain score (SF-36)
Query!
Assessment method [38]
0
0
The SF-36 is a 36-item survey of health and well-being. The scale consists of eight domains: vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning and mental health. The SF-36 will be completed once per session.
Query!
Timepoint [38]
0
0
28 days
Query!
Secondary outcome [39]
0
0
Self-reported general health perceptions score (SF-36)
Query!
Assessment method [39]
0
0
The SF-36 is a 36-item survey of health and well-being. The scale consists of eight domains: vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning and mental health. The SF-36 will be completed once per session.
Query!
Timepoint [39]
0
0
28 days
Query!
Secondary outcome [40]
0
0
Self-reported physical role functioning score (SF-36)
Query!
Assessment method [40]
0
0
The SF-36 is a 36-item survey of health and well-being. The scale consists of eight domains: vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning and mental health. The SF-36 will be completed once per session.
Query!
Timepoint [40]
0
0
28 days
Query!
Secondary outcome [41]
0
0
Self-reported emotional role functioning score (SF-36)
Query!
Assessment method [41]
0
0
The SF-36 is a 36-item survey of health and well-being. The scale consists of eight domains: vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning and mental health. The SF-36 will be completed once per session.
Query!
Timepoint [41]
0
0
28 days
Query!
Secondary outcome [42]
0
0
Self-reported social role functioning score (SF-36)
Query!
Assessment method [42]
0
0
The SF-36 is a 36-item survey of health and well-being. The scale consists of eight domains: vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning and mental health. The SF-36 will be completed once per session.
Query!
Timepoint [42]
0
0
28 days
Query!
Secondary outcome [43]
0
0
Self-reported mental health score (SF-36)
Query!
Assessment method [43]
0
0
The SF-36 is a 36-item survey of health and well-being. The scale consists of eight domains: vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning and mental health. The SF-36 will be completed once per session.
Query!
Timepoint [43]
0
0
28 days
Query!
Secondary outcome [44]
0
0
Self-reported depression score (DASS-21)
Query!
Assessment method [44]
0
0
The Depression, Anxiety and Stress scale (DASS-21) is a 21-item questionnaire that is split into three factors: depression, anxiety and stress. The DASS-21 is made up of affect-related questions pertaining to both physical (e.g. 'dry mouth') and mood symptoms (e.g. 'down-hearted'). Each item is scored on a 4-point scale from 0 to 3, with higher scores indicating a higher degree of dysfunction. It is important to note that lower scores reflect a lack of symptoms and not a more positive mood. Furthermore, as the experience of such symptoms is common in every-day life, the DASS-21 is considered suitable for use in non-clinical settings.
Query!
Timepoint [44]
0
0
28 days
Query!
Secondary outcome [45]
0
0
Self-reported anxiety score (DASS-21)
Query!
Assessment method [45]
0
0
The Depression, Anxiety and Stress scale (DASS-21) is a 21-item questionnaire that is split into three factors: depression, anxiety and stress. The DASS-21 is made up of affect-related questions pertaining to both physical (e.g. 'dry mouth') and mood symptoms (e.g. 'down-hearted'). Each item is scored on a 4-point scale from 0 to 3, with higher scores indicating a higher degree of dysfunction. It is important to note that lower scores reflect a lack of symptoms and not a more positive mood. Furthermore, as the experience of such symptoms is common in every-day life, the DASS-21 is considered suitable for use in non-clinical settings.
Query!
Timepoint [45]
0
0
28 days
Query!
Secondary outcome [46]
0
0
Self-reported stress score (DASS-21)
Query!
Assessment method [46]
0
0
The Depression, Anxiety and Stress scale (DASS-21) is a 21-item questionnaire that is split into three factors: depression, anxiety and stress. The DASS-21 is made up of affect-related questions pertaining to both physical (e.g. 'dry mouth') and mood symptoms (e.g. 'down-hearted'). Each item is scored on a 4-point scale from 0 to 3, with higher scores indicating a higher degree of dysfunction. It is important to note that lower scores reflect a lack of symptoms and not a more positive mood. Furthermore, as the experience of such symptoms is common in every-day life, the DASS-21 is considered suitable for use in non-clinical settings.
Query!
Timepoint [46]
0
0
28 days
Query!
Secondary outcome [47]
0
0
Self-reported confrontive coping score (WAYS)
Query!
Assessment method [47]
0
0
The Ways of Coping Questionnaire (WAYS) is a 66-item scale designed to measure an individual's ability to cope with stress over the past week. The scale measures coping processes, not coping styles. The scale is divided into 8 subscales; confrontive coping, distancing, self-controlling, seeking social support, accepting responsibility, escape-avoidance, planful problem solving, positive re-appraisal. The scale is completed once per session.
Query!
Timepoint [47]
0
0
28 days
Query!
Secondary outcome [48]
0
0
Self-reported distancing score (WAYS)
Query!
Assessment method [48]
0
0
The Ways of Coping Questionnaire (WAYS) is a 66-item scale designed to measure an individual's ability to cope with stress over the past week. The scale measures coping processes, not coping styles. The scale is divided into 8 subscales; confrontive coping, distancing, self-controlling, seeking social support, accepting responsibility, escape-avoidance, planful problem solving, positive re-appraisal. The scale is completed once per session.
Query!
Timepoint [48]
0
0
28 days
Query!
Secondary outcome [49]
0
0
Self-reported self-controlling score (WAYS)
Query!
Assessment method [49]
0
0
The Ways of Coping Questionnaire (WAYS) is a 66-item scale designed to measure an individual's ability to cope with stress over the past week. The scale measures coping processes, not coping styles. The scale is divided into 8 subscales; confrontive coping, distancing, self-controlling, seeking social support, accepting responsibility, escape-avoidance, planful problem solving, positive re-appraisal. The scale is completed once per session.
Query!
Timepoint [49]
0
0
28 days
Query!
Secondary outcome [50]
0
0
Self-reported seeking social support score (WAYS)
Query!
Assessment method [50]
0
0
The Ways of Coping Questionnaire (WAYS) is a 66-item scale designed to measure an individual's ability to cope with stress over the past week. The scale measures coping processes, not coping styles. The scale is divided into 8 subscales; confrontive coping, distancing, self-controlling, seeking social support, accepting responsibility, escape-avoidance, planful problem solving, positive re-appraisal. The scale is completed once per session.
Query!
Timepoint [50]
0
0
28 days
Query!
Secondary outcome [51]
0
0
Self-reported accepting responsibility score (WAYS)
Query!
Assessment method [51]
0
0
The Ways of Coping Questionnaire (WAYS) is a 66-item scale designed to measure an individual's ability to cope with stress over the past week. The scale measures coping processes, not coping styles. The scale is divided into 8 subscales; confrontive coping, distancing, self-controlling, seeking social support, accepting responsibility, escape-avoidance, planful problem solving, positive re-appraisal. The scale is completed once per session.
Query!
Timepoint [51]
0
0
28 days
Query!
Secondary outcome [52]
0
0
Self-reported escape-avoidance score (WAYS)
Query!
Assessment method [52]
0
0
The Ways of Coping Questionnaire (WAYS) is a 66-item scale designed to measure an individual's ability to cope with stress over the past week. The scale measures coping processes, not coping styles. The scale is divided into 8 subscales; confrontive coping, distancing, self-controlling, seeking social support, accepting responsibility, escape-avoidance, planful problem solving, positive re-appraisal. The scale is completed once per session.
Query!
Timepoint [52]
0
0
28 days
Query!
Secondary outcome [53]
0
0
Self-reported planful problem-solving score (WAYS)
Query!
Assessment method [53]
0
0
The Ways of Coping Questionnaire (WAYS) is a 66-item scale designed to measure an individual's ability to cope with stress over the past week. The scale measures coping processes, not coping styles. The scale is divided into 8 subscales; confrontive coping, distancing, self-controlling, seeking social support, accepting responsibility, escape-avoidance, planful problem solving, positive re-appraisal. The scale is completed once per session.
Query!
Timepoint [53]
0
0
28 days
Query!
Secondary outcome [54]
0
0
Self-reported positive re-appraisal score (WAYS)
Query!
Assessment method [54]
0
0
The Ways of Coping Questionnaire (WAYS) is a 66-item scale designed to measure an individual's ability to cope with stress over the past week. The scale measures coping processes, not coping styles. The scale is divided into 8 subscales; confrontive coping, distancing, self-controlling, seeking social support, accepting responsibility, escape-avoidance, planful problem solving, positive re-appraisal. The scale is completed once per session.
Query!
Timepoint [54]
0
0
28 days
Query!
Secondary outcome [55]
0
0
Positive effects of on-trial experiences
Query!
Assessment method [55]
0
0
At the completion of the trial, participants will be asked an open-ended question about any positive effects they may have experienced on their physical or mental health during the study, to allow qualitative analysis of on-trial experiences.
Query!
Timepoint [55]
0
0
28 days
Query!
Secondary outcome [56]
0
0
Negative effects of on-trial experiences
Query!
Assessment method [56]
0
0
At the completion of the trial, participants will be asked an open-ended question about any negative effects they may have experienced on their physical or mental health during the study, to allow qualitative analysis of on-trial experiences.
Query!
Timepoint [56]
0
0
28 days
Query!
Secondary outcome [57]
0
0
Unusual effects of on-trial experiences
Query!
Assessment method [57]
0
0
At the completion of the trial, participants will be asked an open-ended question about any unusual effects they may have experienced on their physical or mental health during the study, to allow qualitative analysis of on-trial experiences.
Query!
Timepoint [57]
0
0
28 days
Query!
Eligibility
Key inclusion criteria
1. Male or female, aged 18-50 years, inclusive.
2. Willing and able to provide written informed consent.
3. Ability of the participant (in the Principal Investigator's opinion) to comprehend the full nature and purpose of the study including possible risks and side effects.
4. Agreement to comply with the protocol and study restrictions.
5. Available for all study visits.
6. Females of child-bearing potential required to provide a negative urine pregnancy test and be using effective contraception (e.g. surgically sterilized (tubal ligation or hysterectomy or partner is post-vasectomy, with sterility confirmed) or use an IUD (intrauterine device), a diaphragm or condom combined with contraceptive sponge, foam or jelly, or be using an oral contraceptive (the pill) for at least 2 cycles before the Screening-visit (Visit 0)).
7. Fluent in written and spoken English.
8. In good general health as judged by the Investigator/Clinical advisor based on medical history.
9. Must have normal, or corrected to normal vision.
10. Body mass index between 18.5 and 29.9kg/m2 (inclusive).
11. Participant is willing to maintain habitual diet (including caffeine and alcohol) and physical activity patterns throughout the study period.
12. Participant is willing and able to comfortably abstain from caffeine for 10 hours prior to and throughout the test visits, (2-3 hours).
13. Participant is willing to abstain from alcohol for 12 hours and vigorous physical activity for 12 hours prior to all study visits.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
50
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
1. History of dementia, stroke and other neurological conditions.
2. Traumatic loss of consciousness in the last 12 months.
3. History of epilepsy or Parkinson's disease.
4. Formal diagnosis of anxiety, depression or any psychiatric disorder that the Principal Investigator believes would interfere with the objectives of the study and requiring treatment (prescription of antidepressant, antipsychotic or other long term medication and/or referral for long term psychotherapy) in the last 2 years. Brief interventions for normal life events such as exam anxiety or bereavement are not an exclusion.
5. Have a significant acute or chronic coexisting illness (cardiovascular, gastrointestinal (irritable bowel syndrome (IBS), inflammatory bowel disease (IBD)), immunological, metabolic (including diabetes or cardiovascular disease), endocrine or bleeding disorders, neurodevelopmental or any condition which contraindicates, in the Principal Investigator's judgement, entry to the study.
6. Uncontrolled hypertension (systolic blood pressure > 160mm Hg or diastolic blood pressure >100 mm Hg).
7. Currently taking (from day of screening onwards) or have previously taken (last 4 weeks prior to screening) psychoactive medication (anxiolytics, sedatives, hypnotics, anti-psychotics, anti-depressants, anti-convulsants, centrally acting corticosteroids, opioid pain relievers).
8. Currently taking (from day of screening onwards) medication that the Principal Investigator believes would interfere with the objectives of the study, pose a safety risk or confound the interpretation of the study results such as:
* high dose anticoagulant medication such as warfarin, heparin, clopidogrel, dabigatran, ticagrelor
* non-steroidal anti-inflammatory drugs (NSAIDS; excluded only for daily use)
* over-the-counter sleep medication (not categorized as sedatives, hypnotics or anti-depressants)
* anti-cholinergic drugs or acetylcholinesterase inhibitors: bethanechol (Urecholine), donepezil (Aricept), rivastigmine (Exelon), galantamine (Reminyl), neostigmine (Prostigmin)
* anti-histamines that cause drowsiness (eg. Ranitidine)
* pseudoephedrine and phenylephrine
9. Currently taking (from day of screening onwards) dietary supplements that the Principal Investigator believes would interfere with the objectives of the study, pose a safety risk or confound the interpretation of the study results such as: melatonin, vitamin E, multivitamins, B vitamin complex, ginkgo biloba, fish oil, St. John's Wort or other cognitive enhancing dietary or herbal supplements over the study period.
10. Recent (within last 4 weeks prior to screening) or ongoing antibiotic therapy during the intervention period.
11. Daily consumption of concentrated sources of probiotics and/or prebiotics within 2 weeks of screening and throughout the intervention period other than the provided study products (e.g., probiotic/prebiotic tablets, capsules, drops or powders or yoghurts/yoghurt drinks containing probiotics).
12. Pregnant or lactating female, or pregnancy planned during intervention period.
13. Have self-reported dyslexia.
14. Current misuse of alcohol, drugs, or prescription medication.
15. Current smoker.
16. Self-declared illicit drug users (including cannabis and cocaine) for 3 weeks prior to screening and during the intervention period.
17. Excessive alcohol consumption (drinking on 5 or more days a week) for 3 weeks prior to screening and during the intervention period.
18. Contraindication to any substance in the investigational product.
19. Participation in another study with any investigational product within 30 days of screening and during the intervention period.
20. Investigator believes that the participant may be uncooperative and/or noncompliant and should therefore not participate in the study.
21. Participant under administrative or legal supervision.
Query!
Study design
Purpose of the study
Other
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 2
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
30/08/2018
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
25/06/2019
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
128
Query!
Recruitment in Australia
Recruitment state(s)
VIC
Query!
Recruitment hospital [1]
0
0
Centre for Human Psychopharmacology, Swinburne University of Technology - Hawthorn
Query!
Recruitment postcode(s) [1]
0
0
3122 - Hawthorn
Query!
Funding & Sponsors
Primary sponsor type
Other
Query!
Name
Swinburne University of Technology
Query!
Address
Query!
Country
Query!
Other collaborator category [1]
0
0
Commercial sector/industry
Query!
Name [1]
0
0
DuPont Nutrition and Health
Query!
Address [1]
0
0
Query!
Country [1]
0
0
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The aim of this study is to demonstrate the effects of 28-days supplementation with a novel probiotic formulation on mental fatigue following a cognitive load in healthy adults. Half of the participants will receive the probiotic formulation while the other half will receive placebo.
Query!
Trial website
https://clinicaltrials.gov/study/NCT03611478
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Andrew B Scholey, PhD
Query!
Address
0
0
Swinburne University of Technology
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
No
Query!
No/undecided IPD sharing reason/comment
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results not provided in
https://clinicaltrials.gov/study/NCT03611478